Launch week offerEnds in00h00m00s

annual Promonthly Pro

Stefan Barth

Professor of Cancer Biotechnology

University of Cape Town

South Africa

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Immunology

Articles (17)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Patrick Arbuthnot

Lecturer/Senior Lecturer/Reader/Personal Professor

University of Witwatersrand

SOUTH AFRICA

View details

G MAKRIGIORGOS

PROFESSOR

Dana-Farber Cancer Institute

UNITED STATES

View details

Suman Alishetty

Research Assistant Professor

George Mason University

UNITED STATES

View details

Mohube Betty Maepa

Associate Professor

University of Witwatersrand

SOUTH AFRICA

View details

Roger Hunter

Researcher

University of Cape Town

SOUTH AFRICA

View details

Klaus Pors

Prof

University of Bradford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stefan Barth

Research Interests

Make your next move.

Explore related searches

Articles (17)

Multi-database transcriptomic screening to identify subtype-selective cell surface targets for development of SNAP-tag based immunotherapeutics

The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast Cancer

Melanotransferrin as a Potential Target for the Selective Killing of Melanoma and Triple-Negative Breast Cancer Cells In Vitro Using Novel SNAP-Tag-Based Antibody–AURIF Conjugate

Carrier-free Peptide-Daunorubicin-siRNA Nanoassembly for Targeted Therapy of Acute Myeloid Leukemia

Overcoming endosomal/lysosomal barriers: Advanced strategies for cytosolic siRNA delivery

Anti-CD64(scFv)-SNAP-Auristatin F: An in vitro proof of concept study for a recombinant antibody conjugate targeting CD64+ acute monocytic leukemia

In vitro anti-tumor activities of a novel recombinant immunotoxin targeting differentially overexpressed Leucine-rich repeat-containing G-protein-coupled receptor 5 in cervical cancer

SNAP‐Tag–Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light‐Accessible Melanotransferrin‐Expressing Melanoma and Triple‐Negative Breast Cancer

Serpin B9‐Insensitive Granzyme B Mutant Delivered by Engineered Capsid AAV Vectors Demonstrates Selective Killing of EGFR‐Positive Cancer Cells

The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma

Revisiting immunotherapeutic strategies for the management of atopic dermatitis

An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates

Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects

AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy

Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy

Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles

The Evolution of SNAP-Tag Labels

Collaborators (6)

Patrick Arbuthnot

G MAKRIGIORGOS

Suman Alishetty

Mohube Betty Maepa

Roger Hunter

Klaus Pors

Make your next move.